Ulf Bremberg

Ulf has a background in medicinal chemistry at Pharmacia/Biovitrum, after earning his PhD in organic chemistry at the Royal Institute of Technology, Sweden and a postdoc with Prof. Rebek, Scripps, La Jolla, USA. After Biovitrum, Ulf has headed up the SciLifeLab Drug Discovery and Development Lead Identification unit and founded several companies in drug discovery. Currently he is leading Beactica research programmes as CSO, with a focus on epigenetic targets.